These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 866764)

  • 1. [Lidocaine and the ventricular preexcitation syndrome].
    Poveda Sierra JJ; Pajarón López A; Ortíz Melón F; Solar Cano J; Daniel Riesco C
    Rev Esp Cardiol; 1977; 30(2):159-64. PubMed ID: 866764
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of lidocaine on supraventricular arrhythmias (author's transl)].
    Cotoi S; Luca C
    G Ital Cardiol; 1976; 6(3):433-9. PubMed ID: 1010194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is safe in the therapy of tachycardic heart arrhythmias?].
    Wehr M; Noll B; Krappe J
    Internist (Berl); 1985 Dec; 26(12):741-9. PubMed ID: 2417980
    [No Abstract]   [Full Text] [Related]  

  • 4. Lidocaine as an antiarrhythmic Experience in 68 patients.
    Flensted-Jensen E; Sandoe E
    Acta Med Scand; 1969 Apr; 185(4):297-302. PubMed ID: 4185142
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical applications of antiarrhythmic drugs.
    Lavenne F; de Jonghe D
    Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias.
    Singh BN
    N Z Med J; 1973 Dec; 78(504):482-6. PubMed ID: 4130662
    [No Abstract]   [Full Text] [Related]  

  • 7. Three therapeutic approaches in tachycardia.
    Preston TA; Yates JD; Brymer JF
    Geriatrics; 1973 Mar; 28(3):110-6. PubMed ID: 4691599
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lidocaine administration in a patient with Wolff-Parkinson-White syndrome and atrial fibrillation (author's transl)].
    Rusconi L; Sermasi S; Marzaloni M; Rossi F
    G Ital Cardiol; 1979; 9(4):428-33. PubMed ID: 456804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of life threatening cardiac arrhythmias.
    Schwartz KM; MacLean WA; Waldo AL
    Cardiovasc Clin; 1981; 11(3):25-48. PubMed ID: 7011556
    [No Abstract]   [Full Text] [Related]  

  • 10. [On ajmaline treatment of heart rhythm disorders].
    Forster G; Holzmann M
    Schweiz Med Wochenschr; 1967 Feb; 97(6):185-93 contd. PubMed ID: 4174226
    [No Abstract]   [Full Text] [Related]  

  • 11. Verapamil in cardiac arrhythmias: an overview.
    Vohra J
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():129-34. PubMed ID: 6749351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-arrhythmic therapy with verapamil by intravenous infusion].
    Furlanello F; Piccolo E; Disertori M; Trevi GP; Lanzetta T; Miori
    Minerva Med; 1975 May; 66(39):1887-903. PubMed ID: 1128829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unfavorable course of the ventricular preexcitation syndrome. Apropos of 3 cases].
    Poveda Sierra J; Pajarón A; Medrano GA
    Arch Inst Cardiol Mex; 1973; 43(6):837-47. PubMed ID: 4773501
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of serious cardiac arrhythmias with drugs.
    Echt DS; Mason JW
    Cardiovasc Clin; 1984; 14(3):191-209. PubMed ID: 6426796
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of flecainide in supraventricular arrhythmias].
    Chouty F; Leclercq JF; Coumel P
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):237-41. PubMed ID: 3740779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of cardiac arrhythmias with N-propyl-ajmalinium-hydrogentartrat (Neo-Gilurytmal (author's transl)].
    So CS; Oversohl K; Seidl KF
    Med Klin; 1974 May; 69(18):814-7. PubMed ID: 4134646
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lidocaine in the therapy of ventricular arrhythmias].
    Pitera A; Kedra M
    Pol Tyg Lek; 1970 Apr; 25(17):595-7. PubMed ID: 4193515
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antiarrhythmic efficacy of mexiletine in supraventricular arrhythmias, Wolff-Parkinson-White syndrome and persistent iterative ventricular hyperkinetic arrhythmias. Considerations on these less noted therapeutic effects].
    Menozzi C; Lolli G; Monducci I; Gheller G; Brignole M; Cattabiani ML; Vergoni W; Barone A
    Clin Ter; 1984 Feb; 108(3):199-208. PubMed ID: 6232057
    [No Abstract]   [Full Text] [Related]  

  • 19. [Di-mono-chloracetyl-ajmaline in the treatment of cardiac rhythm disorders].
    Bucour V; Enesco R; Sirbulesco R; Pompilian P
    Minerva Med; 1970 Jan; 61(5):128-35. PubMed ID: 4189652
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contraindications to the use of digitalis in atrial fibrillation in the course of Wolff-Parkinson-White syndrome].
    Bracchetti D; Binetti G; D'Osualdo F; Magnani B
    Boll Soc Ital Cardiol; 1974; 19(2):181-6. PubMed ID: 4462802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.